TRP_1170x120_4-19-21

the Drug Price Transparency in Medicaid Act

NCPA endorses bill to ban PBM spread pricing tactic

NCPA endorses bill to ban PBM spread pricing tactic

ALEXANDRIA, Va. — The National Community Pharmacists Association is endorsing H.R. 5281, the Drug Price Transparency in Medicaid Act, which would ban the use of spread pricing by pharmacy benefit managers in Medicaid managed care. Currently, PBMs can overbill Medicaid managed care programs, under-reimburse pharmacies for medications dispensed, and retain the difference, which is referred to as